SPHERA FUNDS MANAGEMENT LTD.'s Net Worth
-$3.74 Million
Who is SPHERA FUNDS MANAGEMENT LTD.?
SPHERA FUNDS MANAGEMENT LTD. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Orexigen Therapeutics, Inc., NeurogesX Inc, Werewolf Therapeutics, Inc., and OREXIGEN THERAPEUTICS INC.
SEC CIK
SPHERA FUNDS MANAGEMENT LTD.'s CIK is 0001496201
Past Insider Trading and Trends
2009 was SPHERA FUNDS MANAGEMENT LTD.'s most active year for acquiring shares with 37 total transactions. SPHERA FUNDS MANAGEMENT LTD.'s most active month to acquire stocks was the month of November. 2011 was SPHERA FUNDS MANAGEMENT LTD.'s most active year for disposing of shares, totalling 26 transactions. SPHERA FUNDS MANAGEMENT LTD.'s most active month to dispose stocks was the month of May. 2021 saw SPHERA FUNDS MANAGEMENT LTD. paying a total of $7,600,000.00 for 787,997 shares, this is the most they've acquired in one year. In 2011 SPHERA FUNDS MANAGEMENT LTD. cashed out on 1,264,981 shares for a total of $3,898,206.60, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Orexigen Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.38% | -20.00K |
$4.15 | -$82,990.00 | 571.88K |
Jul 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NeurogesX Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -163.47K |
$2.08 | -$339,745.13 |
0
|
Aug 9 - Aug 10
| |||
Form 4
| -4.99% | -8.58K |
$2.10 | -$18,023.80 | 163.47K |
Jun 24 - Jun 27
| |||
Form 4
| -22.52% | -50.00K |
$2.09 | -$104,535.00 | 172.05K |
Jun 23
| |||
Form 4/A
| -50.90% | -399.00K |
$3.03 | -$1,253,277.49 | 384.81K |
Jun 16
| |||
Form 4
| -50.90% | -399.00K |
$3.03 | -$1,253,277.49 | 384.81K |
Jun 16
| |||
Form 4
| -7.46% | -21.11K |
$2.35 | -$49,421.75 | 261.77K |
Jun 2 - Jun 3
| |||
Form 4
| -3.74% | -11.00K |
$2.46 | -$27,023.70 | 282.88K |
Jun 1
| |||
Form 4
| -4.02% | -12.32K |
$4.07 | -$50,137.21 | 293.88K |
Mar 28
| |||
Form 4
| -22.62% | -152.60K |
$4.03 | -$615,550.28 | 522.05K |
Mar 24
| |||
Form 4
| -3.33% | -33.80K |
$4.00 | -$135,434.38 | 980.84K |
Mar 23
| |||
Form 4
| -4.13% | -14.11K |
$3.67 | -$51,780.37 | 327.89K |
Feb 28 - Mar 1
| |||
Form 4
| +25.47% | 208.84K |
$8.00 | $1,622,381.20 | 1.03M |
Dec 3 - Jul 1
| |||
Form 4
| +99.06% | 408.03K |
$8.38 | $3,401,341.24 | 819.91K |
Sep 11 - Dec 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Werewolf Therapeutics, Inc. (HOWL) Snapshot price: $6.2275
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 788K |
$16.00 |
—
| 788K |
May 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OREXIGEN THERAPEUTICS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||